Spectre G et al. |
Twice daily dosing of aspirin improves platelet inhibition in whole blood in patients with type 2 diabetes mellitus and micro- or macrovascular complications. |
2011 |
Thromb. Haemost. |
pmid:21800009
|
Hoh CM et al. |
Evaluation of effects of low-dose aspirin administration on urinary thromboxane metabolites in healthy dogs. |
2011 |
Am. J. Vet. Res. |
pmid:21801060
|
Dalli E et al. |
Effects of hawthorn (Crataegus laevigata) on platelet aggregation in healthy volunteers. |
2011 |
Thromb. Res. |
pmid:21737127
|
Gao F et al. |
Effect of polymorphism and type II diabetes on aspirin resistance in patients with unstable coronary artery disease. |
2011 |
Chin. Med. J. |
pmid:21740787
|
Lukasik M et al. |
Aspirin treatment influences platelet-related inflammatory biomarkers in healthy individuals but not in acute stroke patients. |
2011 |
Thromb. Res. |
pmid:21788065
|
Shen L et al. |
In vivo oxidation, platelet activation and simultaneous occurrence of natural immunity in atherosclerosis-prone mice. |
2011 |
Isr. Med. Assoc. J. |
pmid:21845968
|
Mattiello T et al. |
Aspirin extrusion from human platelets through multidrug resistance protein-4-mediated transport: evidence of a reduced drug action in patients after coronary artery bypass grafting. |
2011 |
J. Am. Coll. Cardiol. |
pmid:21816313
|
Ramadan E et al. |
Chronic valproate treatment blocks D2-like receptor-mediated brain signaling via arachidonic acid in rats. |
2011 |
Neuropharmacology |
pmid:21839100
|
Lomakin NV and Gruzdev AK |
[Cyclooxygenase inhibitors and antiplatelet effect of acetylsalicylic acid. selective approach to nonsteroidal anti-inflammatory drugs in cardiological practice]. |
2011 |
Kardiologiia |
pmid:21878085
|
Puccetti L et al. |
Effects of atorvastatin and rosuvastatin on thromboxane-dependent platelet activation and oxidative stress in hypercholesterolemia. |
2011 |
Atherosclerosis |
pmid:21056418
|
Basselin M et al. |
Anti-inflammatory effects of chronic aspirin on brain arachidonic acid metabolites. |
2011 |
Neurochem. Res. |
pmid:20981485
|
Trostchansky A et al. |
Nitroarachidonic acid, a novel peroxidase inhibitor of prostaglandin endoperoxide H synthases 1 and 2. |
2011 |
J. Biol. Chem. |
pmid:21266582
|
Trefiletti G et al. |
1-Phenyl-6,7-dihydroxy-isochroman suppresses lipopolysaccharide-induced pro-inflammatory mediator production in human monocytes. |
2011 |
Br. J. Nutr. |
pmid:21269535
|
Gremmel T et al. |
Comparison of methods to evaluate aspirin-mediated platelet inhibition after percutaneous intervention with stent implantation. |
2011 |
Platelets |
pmid:21231857
|
Kuo HL et al. |
NP-313, 2-acetylamino-3-chloro-1,4-naphthoquinone, a novel antithrombotic agent with dual inhibition of thromboxane A(2) synthesis and calcium entry. |
2011 |
Br. J. Pharmacol. |
pmid:21232029
|
Kleinbongard P et al. |
Vasoconstrictor potential of coronary aspirate from patients undergoing stenting of saphenous vein aortocoronary bypass grafts and its pharmacological attenuation. |
2011 |
Circ. Res. |
pmid:21183739
|
Dimitrievska S et al. |
Low thrombogenicity coating of nonwoven PET fiber structures for vascular grafts. |
2011 |
Macromol Biosci |
pmid:21259437
|
Basselin M et al. |
Imaging upregulated brain arachidonic acid metabolism in HIV-1 transgenic rats. |
2011 |
J. Cereb. Blood Flow Metab. |
pmid:20664612
|
Ceprnja M et al. |
Oxidative stress markers in patients with post-traumatic stress disorder. |
2011 |
Coll Antropol |
pmid:22397253
|
Toliopoulos IK et al. |
Inhibition of platelet aggregation and immunomodulation of NK lymphocytes by administration of ascorbic acid. |
2011 |
Indian J. Exp. Biol. |
pmid:22403863
|